Axelsson, Josefin <br/><br/>
mTOR inhibition with temsirolimus causes acute increases in glomerular permeability, but inhibits the dynamic permeability actions of puromycin aminonucleoside.  [electronic resource] 

 -  American journal of physiology. Renal physiology  May 2015 
 - F1056-64 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1522-1466 
<br/><br/><label>Standard No.: </label>10.1152/ajprenal.00632.2014  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiotensin II--pharmacology<br/>Animals<br/>Cell Membrane Permeability--drug effects<br/>Cyclic N-Oxides--pharmacology<br/>Glomerular Filtration Rate--drug effects<br/>Kidney Glomerulus--cytology<br/>Male<br/>Models, Animal<br/>Puromycin Aminonucleoside--pharmacology<br/>Rats<br/>Rats, Wistar<br/>Sirolimus--analogs & derivatives<br/>Spin Labels<br/>TOR Serine-Threonine Kinases--antagonists & inhibitors<br/>Time Factors